• Charity News

ScottishPower help us shine a light on air pollution and cancer

9 December 2021

• For Researchers

How could proposed changes to data protection laws affect research?

As the Government sets out proposals to reform data protection laws, what could this mean for researchers? As the Government sets out proposals to reform data protection laws, what could this mean for researchers?

8 December 2021

• Health & Medicine

How will new cancer medicines be approved in the future?

In the last decade, many more cancer drugs have become available compared to what we’ve seen previously. This has led to more cancer treatment options, but it has also led to more uncertainty about drugs’ clinical benefit and cost-effectiveness. How can this be addressed? In the last decade, many more cancer drugs have become available compared to what we’ve seen previously. This has led to more cancer treatment options, but it has also led to more uncertainty about drugs’ clinical benefit and cost-effectiveness. How can this be addressed?

2 December 2021

• Health & Medicine

Over 600 people in England set to benefit from innovative lung cancer treatment

More than 600 people in England with a form of lung cancer could benefit from the innovative drug osimertinib (Tagrisso) after its approval by the National Institute for Health and Care Excellence. More than 600 people in England with a form of lung cancer could benefit from the innovative drug osimertinib (Tagrisso) after its approval by the National Institute for Health and Care Excellence.

1 December 2021

• Science & Technology
• For Supporters

Touching a nerve: How neuroscience could advance our understanding of cancer

The role of the nervous system in cancer progression remains largely unexplored. Now, our researchers at the Francis Crick Institute and Cancer Research UK Edinburgh Centre are leaning into the unknown to find out how cancer uses nerve cells and networks to survive and grow. The role of the nervous system in cancer progression remains largely unexplored. Now, our researchers at the Francis Crick Institute and Cancer Research UK Edinburgh Centre are leaning into the unknown to find out how cancer uses nerve cells and networks to survive and grow.

1 December 2021

• Policy & Insight
• For Supporters

“Supporting research is mission critical for me and always will be” – Philanthropy award winners share their stories

Jill May and David Dangoor CBE tell us why they’ve devoted time, effort and millions of pounds to back our vital research.   Jill May and David Dangoor CBE tell us why they’ve devoted time, effort and millions of pounds to back our vital research.  

29 November 2021

• Health & Medicine

Targeted drug recommended to treat some advanced lung cancer patients

Selpercatinib will expand treatment options available for people with RET fusion positive non small cell lung cancer on the NHS in England. Selpercatinib will expand treatment options available for people with RET fusion positive non small cell lung cancer on the NHS in England.

25 November 2021

• Policy & Insight

A Cancer Revolution comes to Manchester: Patrick’s review

How exactly do you create an exhibition looking at the hugely complex and emotive subject of cancer? You do exactly what the Science Museum has done in its superb exhibition, which I had the pleasure of attending last month. How exactly do you create an exhibition looking at the hugely complex and emotive subject of cancer? You do exactly what the Science Museum has done in its superb exhibition, which I had the pleasure of attending last month.

24 November 2021

• Health & Medicine

Childhood cancer survivors at greater risk of ill health

People who survive cancer in childhood have a higher risk of ill health as they grow older, according to new research published in The Lancet Regional Health – Europe. People who survive cancer in childhood have a higher risk of ill health as they grow older, according to new research published in The Lancet Regional Health – Europe.

22 November 2021

• For Researchers

The incredible value of going public

We speak with two science communication masters about the benefits, ethics and sheer fun of communicating your research to the public. We speak with two science communication masters about the benefits, ethics and sheer fun of communicating your research to the public.

22 November 2021

• Science & Technology
• For Supporters

Bjorn Saven: “By supporting early career researchers to do their jobs really well, we can help move the world forward”

We speak with the industrialist, investor and Cancer Research UK supporter about his substantial donation to support our early career researchers… and why he changed his mind about cancer research. We speak with the industrialist, investor and Cancer Research UK supporter about his substantial donation to support our early career researchers… and why he changed his mind about cancer research.

19 November 2021